Merck appoints Surendralal L. Karsanbhai to its board of directors Merck appoints Surendralal L. Karsanbhai to its board of directors The President and CEO of Emerson Electric will work with the 13-strong board to oversee the management of Merck's global business endeavours Pfizer appoints Chris Boshoff as Chief Scientific Officer and President of R&D Pfizer appoints Chris Boshoff as Chief Scientific Officer and President of R&D Dr Boshoff will be responsible for overseeing and advancing Pfizer's R&D initiatives across all therapeutic areas Biosynth appoints Matt Gunnison as its new CEO and Kieran Murphy as Chair Biosynth appoints Matt Gunnison as its new CEO and Kieran Murphy as Chair Matt and will both assume their places on the Board of Directors, and will work to strengthen the company's position in the life sciences sector Wheeler Bio appoints Patrick Lucy as chief executive officer Wheeler Bio appoints Patrick Lucy as chief executive officer Experienced leader to guide the company towards integrated commercial-scale operations Calluna Pharma appoints Mark Gaffney as CEO and Mark Altmeyer as Chair of the Board Calluna Pharma appoints Mark Gaffney as CEO and Mark Altmeyer as Chair of the Board The two will work to advance the company's global presence, while developing its lead programme Mosaic Therapeutics appoints Dr Barry Davies as its CSO Mosaic Therapeutics appoints Dr Barry Davies as its CSO Barry will bring more than 25 years of experience in drug development and lead optimisation to the table Lonza nominates David Meline as independent board member Lonza nominates David Meline as independent board member David Meline brings extensive governance, financial and industry experience to Lonza’s Board of Directors Nanosyrinx appoints Edwin Moses as its Chairperson Nanosyrinx appoints Edwin Moses as its Chairperson With more than 30 years of executive-level experience, Edwin will aim to maximise the value of the company's nanosyringe platform Enzene appoints Norm Stoffregen as Site Head of its US biomanufacturing facility Enzene appoints Norm Stoffregen as Site Head of its US biomanufacturing facility The CDMO has appointed Norm to run the USD $50m manufacturing facility in New Jersey Amphista Therapeutics appoints new CEO, Antony Mattessich Amphista Therapeutics appoints new CEO, Antony Mattessich Antony will be responsible for assisting the growth and development of the company and its therapeutic assets Johnson & Johnson's Kristen Mulholland appointed as Chief Human Resources Officer Johnson & Johnson's Kristen Mulholland appointed as Chief Human Resources Officer Kristen will replace Peter Fasolo, who will retire after 16 years of service for the company Jochen Schmidt appointed new Managing Director of Romaco Pharmatechnik GmbH Jochen Schmidt appointed new Managing Director of Romaco Pharmatechnik GmbH Romaco Holding GmbH has just appointed Jochen Schmidt as new Managing Director of Romaco Pharmatechnik GmbH. He will be responsible with immediate effect for the Romaco... Bio X Cell appoints Christopher Conway as CEO Bio X Cell appoints Christopher Conway as CEO Christopher will work with the executive board members to guide the company's global expansion strategy Emirates Biotech bolsters executive board with four new appointments Emirates Biotech bolsters executive board with four new appointments The company has brought in a new CEO, CCO, CTO and a Head of Finance to boost its footprint in the Middle East, Africa and India Corex Logistics appoints Steve Healy as its new CEO Corex Logistics appoints Steve Healy as its new CEO Steve will guide the company's global expansion initiative Lonza appoints Juan Andres and Eric Drapé to its Board as independent members Lonza appoints Juan Andres and Eric Drapé to its Board as independent members The two bring a wealth of pharmaceutical knowledge, and have worked in a number of leadership positions at pharma giants such as Novo Nordisk, Moderna and Eli Lilly